Multiple Myeloma at First Relapse
2 clinical trials · Condition
◉ Watch Multiple Myeloma at First Relapse
| Record | Firm | Date |
|---|---|---|
| Real-World Use of Selinexor, Daratumumab and Dexamethasone in Chinese Patients With Multiple Myeloma at First Relapse (NCT05559788) | Fu chengcheng PhD | 2022-09-20 |
| A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (NCT04998786) | Nantes University Hospital | 2021-12-14 |
Track Multiple Myeloma at First Relapse automatically
Every clearance here is in the API, with alerts when new ones post.